To learn more, please call our Research Department at (513) 936-5388 or (888) 649-4800. Or email abradley@ohcmail.com
Study number:
BRE 177 Amgen 20060359
Protocol title:
A Randomzed, Double-blind, Placebo-Controlled, Multi-Center
Phase 3 Study of Dennosumab as Adjuvant Treatment for women
with Early-stage Breast Cancer at High Risk of Recurrence
(D-CARE)
Status:
Open
- Study number:
- BRE 163 B-46-I/07132 USO/NSABP
- Protocol title:
- Phase III Clinical Trial Comparing the Combination of TC Plus Bevacixumab to TC Alone and to TAC for Women with Node-Positive or High-Risk Node-Negative Early Breast Cancer
- Status:
- Open
Study number:
BRE 179 Celldex Therapeutics CDX011-03
Protocol title:
A Phase II, Randomized, Multicenter Study of CDX-011 in Patients
with Advanced GPNMB-Expressing Breast Cancer
Status:
Open
-
- LOCALLY ADVANCED/METASTATIC, FIRST LINE, HER2-
- Study number:
- BRE 138 SCRI
- Protocol title:
- Phase I/II Trial of Sorafenib Plus Ixabepilone as First-Line Treatment for Patients with HER2-Negative Metastatic Breast Cancer
- Status:
- Open
-
-
- METASTATIC, FIRST LINE, HER2+
- Study number:
- BRE 171 Hoffmann-LaRoche Inc.B022589B/TDM 4788g B-ROW
- Protocol title:
- A Randomized, 3 ARM, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of T-DM1 Combined with Pertuzumab or T-DM1 Combined with Pertuzumab or Placebo, Versus the Combination of Herceptin plus taxane, as First-line Treatment in HER2 Positive Progressive or Recurrent Locally Advanced or Metastatic Breast Cancer
- Status:
- Open
-
- Locally advanced/Metastatic after Taxane and Doxorubicin
- Study number:
- BRE 183 ImClone Systems, Inc. IMCL CP20-0903
- Protocol title:
- An Open Label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of Ramucirumab (IMC1121B) Drug Product or IMC18F in Combination with Capecitabine or Capecitabine Monotherapy, in Unrespectable, Locally-advanced or Metastatic Breast Cancer Patients Previously Treated with Anthracycline and Taxane Therapy
- Status:
- Open
-
-
- METASTATIC OBSERVATIONAL
- Study number:
- BRE 150 AVF4349n Genentech, Inc.
- Protocol title:
- An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer
- Status:
- Open
- RADIATION
- Study number:
- NSABP B-39
- Protocol title:
- A Randomized Phase 3 Study of Conventional Whole Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) for Women w/Stage 0,I or II Breast Cancer
- Status:
- Open